Article
A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder
The current study assessed the long-term metabolic effects of aripiprazole monotherapy relative to lithium monotherapy for the treatment of bipolar I disorder.